Patents by Inventor Kenneth Poss

Kenneth Poss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11952434
    Abstract: The present disclosure provides compounds which are immunomodulators and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
    Type: Grant
    Filed: April 20, 2022
    Date of Patent: April 9, 2024
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kevin W. Gillman, Jason Goodrich, Kenneth M. Boy, Yunhui Zhang, Claudio Mapelli, Michael A. Poss, Paul Michael Scola, David R. Langley, Nicholas A. Meanwell
  • Publication number: 20240050593
    Abstract: Disclosed herein are compositions and methods of treating a spinal cord injury and improving spinal cord function. Also disclosed are compositions and methods of stimulating regeneration, promoting glial cell proliferation, promoting axonal tract regeneration, triggering neurite outgrowth, and triggering neuron formation in injured and/or damaged spinal cord tissue.
    Type: Application
    Filed: December 15, 2021
    Publication date: February 15, 2024
    Applicant: Duke University
    Inventors: Kenneth Poss, Valentina Cigliola, Adam Shoffner
  • Publication number: 20240026355
    Abstract: Disclosed herein are methods are compositions and methods for enhancing regeneration in stressed damaged, and/or injured tissues.
    Type: Application
    Filed: November 16, 2021
    Publication date: January 25, 2024
    Applicant: Duke University
    Inventors: Kenneth Poss, Ruorong Yan, Junsu Kang, Joseph Goldman, Valentia Cigliola